Literature DB >> 1540039

Peripheral vascular disease in patients with systemic lupus erythematosus.

J McDonald1, J Stewart, M B Urowitz, D D Gladman.   

Abstract

Patients with systemic lupus erythematosus may develop premature atherosclerosis, notably coronary artery disease. A group of 10 patients with peripheral vascular disease presenting with intermittent claudication or gangrene were studied from a group of 563 patients followed prospectively at the Wellesley Hospital Lupus Clinic. These 10 patients were compared with the next lupus clinic patient matched for age and sex, with respect to demographic characteristics and risk factors. The patients and controls did not differ significantly in lupus activity criteria count, partial thromboplastin time, the number with antibody to cardiolipin, number receiving steroids or mean steroid dose, family history of atherosclerosis, hyperlipidaemia, smoking, hypertension or use of oral contraceptives. The risk factors for developing peripheral vascular disease were a longer duration of systemic lupus erythematosus and a longer duration of use of steroids. Eight of the 10 patients had coexistent coronary artery disease or transient ischaemic attack.

Entities:  

Mesh:

Year:  1992        PMID: 1540039      PMCID: PMC1004619          DOI: 10.1136/ard.51.1.56

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Gangrene of the legs in disseminated lupus erythematosus.

Authors:  E C KEAT; J H SHORE
Journal:  Br Med J       Date:  1958-01-04

Review 2.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

3.  The bimodal mortality pattern of systemic lupus erythematosus.

Authors:  M B Urowitz; A A Bookman; B E Koehler; D A Gordon; H A Smythe; M A Ogryzlo
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

4.  Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus.

Authors:  J Meller; C A Conde; L M Deppisch; E Donoso; S Dack
Journal:  Am J Cardiol       Date:  1975-02       Impact factor: 2.778

5.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

6.  Mortality in systemic lupus erythematosus: the bimodal pattern revisited.

Authors:  L A Rubin; M B Urowitz; D D Gladman
Journal:  Q J Med       Date:  1985-04

7.  Myocardial infarction in four young patients with SLE.

Authors:  H Spiera; R R Rothenberg
Journal:  J Rheumatol       Date:  1983-06       Impact factor: 4.666

8.  Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.

Authors:  E N Harris; A E Gharavi; R A Asherson; M L Boey; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

9.  Gangrene of a foot secondary to systemic lupus erythematosus with large vessel vasculitis.

Authors:  G S Gladstein; R I Rynes; N Parhami; L E Bartholomew
Journal:  J Rheumatol       Date:  1979 Sep-Oct       Impact factor: 4.666

10.  Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors:  R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

View more
  6 in total

Review 1.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

Review 2.  Atherosclerosis and systemic lupus erythematosus.

Authors:  M Urowitz; D Gladman; I Bruce
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

3.  High prevalence of asymptomatically poor muscle perfusion of lower extremities measured in systemic lupus erythematosus patients with abnormal myocardial perfusion.

Authors:  C C Lin; H J Ding; Y W Chen; J J Wang; S T Ho; A Kao
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

4.  Usefulness of thallium-201 muscle scan to investigate perfusion reserve in the lower limbs of patients with systemic lupus erythematusus.

Authors:  H B Hsu; S S Sun; J J H Chen; J J P Tsai; C H Kao; S P ChangLai
Journal:  Rheumatol Int       Date:  2003-08-14       Impact factor: 2.631

5.  A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia.

Authors:  Hendrik Gremmels; Martin Teraa; Saskia C A de Jager; Gerard Pasterkamp; Gert J de Borst; Marianne C Verhaar
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

6.  Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study.

Authors:  Ya-Wen Chuang; Mei-Ching Yu; Cheng-Li Lin; Tung-Min Yu; Kuo-Hsiung Shu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.